|Articles|April 1, 2019
- Pharmaceutical Executive-04-01-2019
- Volume 39
- Issue 4
Pharmaceutical Executive, April 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Biosimilars Name Game Remains Thorny Issueover 7 years ago
HBA's Woman of the Year 2019over 7 years ago
Sharing Your Voiceover 7 years ago
Health Technology’s Double-Edged Swordover 7 years ago
True Grit: Talent Management from the Ground Upover 7 years ago
Reinventing Pharma’s Talent Searchover 7 years ago
Hiring a Chief Diversity Officerover 7 years ago
Are Pharma Marketers Fighting the Last War?over 7 years ago
Ready Patient Oneover 7 years ago
Country Report: ChinaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5